CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | KANEKO YASUNORI Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-06-06 | Lacey David L. Director | Grant or award | +8,400 | 57,652 | ||
| 2024-06-06 | Lacey David L. Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-06-06 | FALBERG KATHRYN E Director | Grant or award | +8,400 | 55,300 | ||
| 2024-06-06 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-06-06 | Machado Patrick Director | Grant or award | +8,400 | 25,300 | ||
| 2024-06-06 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-06-06 | PERLMAN ANDREW J Director | Grant or award | +8,400 | 29,325 | ||
| 2024-06-06 | PERLMAN ANDREW J Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-06-06 | Ribas Antoni Director | Grant or award | +8,400 | 30,350 | ||
| 2024-06-06 | Ribas Antoni Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-06-06 | Lambert Nicole Director | Grant or award | +8,400 | 24,000 | ||
| 2024-06-06 | Lambert Nicole Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2024-03-27 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −11,551 | $17.55 | $203K | 215,253 |
| 2024-03-18 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −12,153 | $17.84 | $217K | 228,100 |
| 2024-03-18 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −1,296 | $18.62 | $24K | 226,804 |
| 2024-02-27 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −34,070 | $20.11 | $685K | 240,253 |
| 2024-02-27 | Jaen Juan C. President | Sale 10b5-1 | −23,132 | $20.10 | $465K | 1,188,233 |
| 2024-02-26 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −24,555 | $20.07 | $493K | 274,323 |
| 2024-02-26 | Jaen Juan C. President | Sale 10b5-1 | −3,900 | $20.06 | $78K | 1,211,365 |
Page 8 of 9 · 177 trades